Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A, Bromberg J, Touitou V, Sobolewska B, Missotten T, Baarsma S, Hoyng C, Cordero-Coma M, Tomkins-Netzer O, Rozalski A, Tugal-Tutkun I, Guex-Crosier Y, Los LI, Bollemeijer JG, Nolan A, Pawade J, Willermain F, Bodaghi B, ten Dam-van Loon N, Dick A, Zierhut M, Lightman S, Mackensen F, Moulin A, Erckens R, Wensing B, le Hoang P, Lokhorst H, Rothova A. Riemens A, et al. Among authors: mackensen f. JAMA Ophthalmol. 2015 Feb;133(2):191-7. doi: 10.1001/jamaophthalmol.2014.4755. JAMA Ophthalmol. 2015. PMID: 25412269 Free article.
Acute Retinal Necrosis: Diagnostic and Treatment Strategies in Germany.
Winterhalter S, Stuebiger N, Maier AK, Pleyer U, Heiligenhaus A, Mackensen F, Zierhut M, Joussen AM, Ness T. Winterhalter S, et al. Among authors: mackensen f. Ocul Immunol Inflamm. 2016 Oct;24(5):537-43. doi: 10.3109/09273948.2015.1034375. Epub 2015 Sep 23. Ocul Immunol Inflamm. 2016. PMID: 26399848
Enteric-coated mycophenolate sodium in the treatment of non-infectious intermediate uveitis: results of a prospective, controlled, randomised, open-label, early terminated multicentre trial.
Deuter CME, Engelmann K, Heiligenhaus A, Lanzl I, Mackensen F, Ness T, Pleyer U, Stuebiger N, Wilhelm B, Luedtke H, Zierhut M, Doycheva D; MYCUV-IIT02 Study Group. Deuter CME, et al. Among authors: mackensen f. Br J Ophthalmol. 2018 May;102(5):647-653. doi: 10.1136/bjophthalmol-2017-310156. Epub 2017 Sep 13. Br J Ophthalmol. 2018. PMID: 28903965 Clinical Trial.
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.
Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR. Larkin KL, et al. Among authors: mackensen f. Br J Ophthalmol. 2014 Jan;98(1):99-103. doi: 10.1136/bjophthalmol-2013-304043. Epub 2013 Oct 24. Br J Ophthalmol. 2014. PMID: 24158837
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.
Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH. Sarens IL, et al. Among authors: mackensen f. Am J Ophthalmol. 2018 Mar;187:158-166. doi: 10.1016/j.ajo.2017.08.017. Epub 2017 Sep 6. Am J Ophthalmol. 2018. PMID: 28887115 Free article.
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM, Arevalo JF, Ziemssen F, Mehio-Sibai A, Mackensen F, Adan A, Chan WM, Ness T, Banker AS, Dodwell D, Chau Tran TH, Fardeau C, Lehoang P, Mahendradas P, Berrocal M, Tabbarah Z, Hrisomalos N, Hrisomalos F, Al-Salem K, Guthoff R. Mansour AM, et al. Among authors: mackensen f. Am J Ophthalmol. 2009 Aug;148(2):310-316.e2. doi: 10.1016/j.ajo.2009.03.023. Epub 2009 May 9. Am J Ophthalmol. 2009. PMID: 19427992
74 results